SightfileU.S. market data from official filings

Scilex Holding Co (SCLX)

Name: Scilex Holding Co (SCLX) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001820190 · EDGAR filings · Updated 2026-07-22

Scilex Holding Co (SCLX) has reported institutional ownership of 10.3%, with 71 institutional managers holding positions valued at $5.81M per the latest 13F reporting period. SEC filings include an active non-reliance notice on previously issued financial statements (8-K Item 4.02), notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

10.3%

Institutional managers

Reported 13F value

$5.81M

Insider activity

3 trans.

−$12.8M net selling

Data flags

3 active

from SEC filings

Filings this week (1)

2026-07-22 — Current report (8-K) filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

2026-07-07 — SCHEDULE 13D/A filed
2026-07-07 — Insider transaction reported (Form 4)
2026-07-06 — Current report (8-K) filed
2026-06-30 — Employee-plan registration (S-8) filed
2026-06-29 — Current report (8-K) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Scilex Holding Co has 71 institutional holders and institutional ownership of 10.3%.

Insider activity

Insiders reported 3 transactions (0 buys, 3 sells) across 1 reporting insiders, with a net reported value of −$12.8M.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-20 (recurring since 2021-03-31) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2024-11-22 (recurring since 2021-06-01) — source filing. The authoritative details are those stated in the filing itself.

Active non-reliance notice on previously issued financial statements (8-K Item 4.02), most recently filed 2021-12-07 (recurring since 2021-12-07) — source filing. The authoritative details are those stated in the filing itself.

Related companies

INMUNE BIO INC (INMB) · APOLLOMICS INC (APLM) · CYPHERPUNK TECHNOLOGIES INC (CYPH) · Natural Alternatives International Inc (NAII) · Vivani Medical Inc (VANI) · IN8BIO INC (INAB)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-22.